Phosphate wasting disorders in adults

被引：28

作者：

Marcucci, G. ^{[1
]}

Masi, L. ^{[1
]}

Ferrari, S. ^{[2
,3
]}

Haffner, D. ^{[4
]}

Javaid, M. K. ^{[5
]}

Kamenicky, P. ^{[6
]}

Reginster, J. -Y. ^{[7
]}

Rizzoli, R. ^{[2
,3
]}

Brandi, M. L. ^{[1
]}

机构：

[1] Univ Florence, Dept Surg & Translat Med, Metab Bone Dis Unit, Florence, Italy

[2] Geneva Univ Hosp, Div Bone Dis, Geneva, Switzerland

[3] Fac Med, Geneva, Switzerland

[4] Hannover Med Sch, Dept Pediat Kidney Liver & Metab Dis, Hannover, Germany

[5] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

[6] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Ctr Reference Malad Rares Metab Calcium & Phospho, F-94275 Le Kremlin Bicetre, France

[7] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium

来源：

OSTEOPOROSIS INTERNATIONAL | 2018年 / 29卷 / 11期

关键词：

FGF-23; Hypophosphatemia; Osteomalacia; Phosphate wasting disorders; Rickets; Treatment; FIBROBLAST GROWTH FACTOR-23; LINKED HYPOPHOSPHATEMIC RICKETS; TUMOR-INDUCED OSTEOMALACIA; VITAMIN-D-RECEPTOR; HORMONE TREATMENT; PARATHYROID-HORMONE; PRIMARY HYPERPARATHYROIDISM; FIBROUS DYSPLASIA; SERUM PHOSPHORUS; SHORT CHILDREN;

D O I：

10.1007/s00198-018-4618-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A cause of hypophosphatemia is phosphate wasting disorders. Knowledge concerning mechanisms involved in phosphate wasting disorders has greatly increased in the last decade by the identification of phosphatonins, among them FGF-23. FGF-23 is a primarily bone derived factor decreasing renal tubular reabsorption of phosphate and the synthesis of calcitriol. Currently, pharmacological treatment of these disorders offers limited efficacy and is potentially associated to gastrointestinal, renal, and parathyroid complications; therefore, efforts have been directed toward newer pharmacological strategies that target the FGF-23 pathway. This review focuses on phosphate metabolism, its main regulators, and phosphate wasting disorders in adults, highlighting the main issues related to diagnosis and current and new potential treatments.

引用

页码：2369 / 2387

页数：19

共 50 条

[21] EXPRESSION OF PHOSPHATE WASTING DISORDER IN THE ADULT
Javaid, K.
OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S80 - S81
[22] Wasting disorders of early infancy.
Parsons, LG
LANCET, 1924, 1 : 687 - 694
[23] Cardiac Cachexia - A Window to the Wasting Disorders
Coats, Andrew J. Stewart
ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2018, 110 (01) : 102 - 102
[24] Wasting disorders of early infancy.
Parsons, LG
LANCET, 1924, 1 : 939 - 946
[25] Therapeutic approaches for muscle wasting disorders
Lynch, Gordon S.
Schertzer, Jonathan D.
Ryall, James G.
PHARMACOLOGY & THERAPEUTICS, 2007, 113 (03) : 461 - 487
[26] CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders
Bai, Xiuying
Miao, Dengshun
Xiao, Sophia
Qiu, Dinghong
St-Arnaud, Rene
Petkovich, Martin
Gupta, Ajay
Goltzman, David
Karaplis, Andrew C.
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (02): : 667 - 680
[27] A complex case of renal phosphate wasting...
Daude, Sebastien
Quinaux, Thomas
Collet-Fenetrier, Benjamin
Silve, Caroline
Okamba, Patricia
Tubail, Zead
Savenkoff, Benjamin
NEPHROLOGIE & THERAPEUTIQUE, 2021, 17 (06): : 466 - 472
[28] Iron Chelation Resulting in Renal Phosphate Wasting
Cheddani, Lynda
Leblanc, Thierry
Silve, Caroline
Tabibzadeh, Nahid
Prie, Dominique
Haymann, Jean-Philippe
Peraldi, Marie-Noelle
Daudon, Michel
Meria, Paul
Letavernier, Emmanuel
KIDNEY INTERNATIONAL REPORTS, 2018, 3 (01): : 1 - 4
[29] Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomy
McKenna, Malachi J.
Martin-Grace, Julie
Crowley, Rachel
Twomey, Patrick J.
Kilbane, Mark T.
JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (04) : 685 - 693
[30] Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomy
Malachi J. McKenna
Julie Martin-Grace
Rachel Crowley
Patrick J. Twomey
Mark T. Kilbane
Journal of Bone and Mineral Metabolism, 2019, 37 : 685 - 693

← 1 2 3 4 5 →